SKI Market

A+| A| A-|

Indian Indices

Sensex

74,855.22 295.98
( 0.40%)

Global Indices

Nasdaq

49,785.17 59.69
(0.12%)

Dow Jones

7,421.51 -12.33
(-0.17%)

Hang Seng

63,198.64 456.07
(0.73%)

Nikkei 225

10,253.59 -15.84
(-0.15%)

Forex

USD-INR

95.14 0.72
(0.77%)

EUR-INR

111.99 0.76
(0.69%)

GBP-INR

129.47 0.85
(0.66%)

JPY-INR

0.61 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.85

106009.78

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.63

Back

emerald finserv ltd

Natural Capsules reports consolidated net loss of Rs 7.12 crore in the December 2025 quarter

Feb 14,2026

Net loss of Natural Capsules reported to Rs 7.12 crore in the quarter ended December 2025 as against net profit of Rs 0.11 crore during the previous quarter ended December 2024. Sales declined 13.87% to Rs 37.75 crore in the quarter ended December 2025 as against Rs 43.83 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	37.75	43.83	-14
OPM %	-6.17	9.74	-
PBDT	-4.72	2.84	PL
PBT	-9.08	0.50	PL
NP	-7.12	0.11	PL

74,855.22 295.98 ( 0.40%)

49,785.17 59.69 (0.12%)

7,421.51 -12.33 (-0.17%)

63,198.64 456.07 (0.73%)

10,253.59 -15.84 (-0.15%)

95.14 0.72 (0.77%)

111.99 0.76 (0.69%)

129.47 0.85 (0.66%)

0.61 0.00 (0.51%)